CINECA IRIS Institutional Research Information System

DANIELE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.378
EU - Europa 2.163
AS - Asia 860
AF - Africa 100
SA - Sud America 37
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.199
IT - Italia 1.167
CN - Cina 421
SE - Svezia 334
SG - Singapore 242
CA - Canada 176
BG - Bulgaria 167
GB - Regno Unito 113
DE - Germania 109
AT - Austria 74
VN - Vietnam 68
CI - Costa d'Avorio 62
FI - Finlandia 45
HK - Hong Kong 33
FR - Francia 30
BR - Brasile 29
TR - Turchia 29
IN - India 25
RU - Federazione Russa 23
SN - Senegal 21
BE - Belgio 17
IE - Irlanda 17
PL - Polonia 15
CH - Svizzera 11
NG - Nigeria 11
JP - Giappone 10
UA - Ucraina 9
TW - Taiwan 8
LT - Lituania 7
IR - Iran 6
PT - Portogallo 6
AU - Australia 4
CZ - Repubblica Ceca 4
KR - Corea 4
NL - Olanda 4
BJ - Benin 3
MY - Malesia 3
RO - Romania 3
UY - Uruguay 3
CO - Colombia 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
MA - Marocco 2
MX - Messico 2
OM - Oman 2
UZ - Uzbekistan 2
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.545
Salva come PNG Salva come JPEG
Città #
Woodbridge 538
Fairfield 489
Ann Arbor 430
Houston 361
Santa Clara 343
Chandler 251
Serra 247
Ashburn 232
Seattle 209
Cambridge 172
Milan 167
Sofia 164
Ottawa 156
Wilmington 152
Singapore 126
Shanghai 123
Beijing 121
New York 121
Boardman 83
Pisa 81
Princeton 79
Florence 77
Lawrence 68
Abidjan 62
Rome 60
Vienna 56
Medford 53
Des Moines 39
Lancaster 39
Redwood City 34
Dong Ket 31
Hong Kong 31
London 30
Frankfurt am Main 28
Dearborn 25
San Diego 24
Boulder 21
Bremen 21
Chicago 21
Dakar 21
Nanjing 21
Istanbul 20
Marseille 18
Naples 18
Brussels 17
Mendicino 17
Fuzhou 16
Ogden 15
Helsinki 14
Los Angeles 14
Sligo 13
Warsaw 13
Lagos 11
Tianjin 11
Verona 10
Dallas 9
Munich 9
Bern 8
Cascina 8
Cava Dei Tirreni 8
Changsha 8
San Francisco 8
Shenyang 8
Gallarate 7
Guangzhou 7
Izmir 7
Montréal 7
Taipei 7
Hebei 6
Kunming 6
Nanchang 6
Norwalk 6
Quanzhou 6
Toronto 6
Turin 6
Castelfranco Veneto 5
Catania 5
Hefei 5
Livorno 5
Parma 5
Pocatello 5
Pune 5
Wuhan 5
Xiamen 5
Cologno Monzese 4
Falls Church 4
Giugliano in Campania 4
Jacksonville 4
Moate 4
Portici 4
Redmond 4
Santa Maria a Monte 4
Sesto Fiorentino 4
Trezzo Sull'adda 4
Acri 3
Auburn Hills 3
Avellino 3
Bologna 3
Brescia 3
Brno 3
Totale 5.860
Salva come PNG Salva come JPEG
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 494
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 171
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 168
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 150
Dapagliflozin lowers plasma glucose concentration and improves β-cell function 145
Prognostic implications of diabetes phenotyping: new concepts for an old disease 142
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 142
null 142
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System 138
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 135
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 133
Exenatide modulates visual cortex responses 132
Ectopic fat: The true culprit linking obesity and cardiovascular disease? 131
Insulin resistance and endothelial dysfunction: A mutual relationship in cardiometabolic risk 128
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 125
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 124
Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males 123
The effects of bariatric surgery on the brain glucose metabolism and its biological mediators: an insight from dynamic 18F-FDG PET/CT study 122
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 117
I nuovi farmaci per il diabete: gli inibitori del co-trasportatore sodio-glucosio di tipo 2 (SGLT-2i) 116
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 116
null 115
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study 112
Discordance between central (Brain) and pancreatic action of exenatide in lean and obese subjects 110
null 108
Altered Visual Plasticity in Morbidly Obese Subjects 108
Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes 108
Determinants of the Increase in Fasting Plasma Ketone Concentration during SGLT2 Inhibition in NGT, IFG and T2DM Patients 107
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 107
Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg muscles 106
GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach 105
Terapia con metformina e rischio di acidosi lattica 104
Pioglitazone Inhibits Mitochondrial Pyruvate Metabolism and Glucose Production in Hepatocytes 103
THE METABOLIC SYNDROME IS RELATED TO ALBUMINURIA IN TYPE 2 DIABETES 102
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 101
Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones 101
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 98
Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus 96
null 96
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 95
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 93
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 91
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism 88
Effects of Treatment With Metformin and/or Sitagliptin on Beta-cell Function and Insulin Resistance in Prediabetic Women With Previous Gestational Diabetes 88
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery 86
null 84
null 83
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 80
Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity 79
Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes 77
null 76
Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge 75
Empagliflozin Treatment is Associated with Improved Beta Cell Function in T2DM 73
Invited review. Series: Implications of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? 71
Brain effect of bariatric surgery in people with obesity 66
Effects of Intermittent Fasting on Brain Metabolism 65
Abnormalities of Insulin Secretion and ß-Cell Defects in Type 2 Diabetes 65
null 63
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 63
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 62
Cognitive Function and Brain Plasticity in Obese Patients—The Impact of Bariatric Surgery 61
null 60
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes 58
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance 56
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas 54
The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans 50
Inhibition of Renal Sodium-Glucose Co-Transport with Empagliflozin Lowers Fasting Plasma Glucose and Improves Beta Cell Function in Subjects With Impaired Fasting Glucose 49
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion 49
null 48
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study. diabetes care 2020;43:E139–e141 47
Renal Denervation Attenuates Endogenous Glucose Production Increase with SGLT2 Inhibition in Patients with Renal Transplant Recipients and Impaired Fasting Glucose 47
Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report 47
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes 43
Access to emergency room for hypoglycaemia in people with diabetes 43
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humans 35
null 32
Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization 30
Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant 29
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report 28
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals 24
Near-Infrared Spectroscopy: A Free-Living Neuroscience Tool to Better Understand Diabetes and Obesity 22
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production 22
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 18
Treatment with Oral Drugs 17
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients 16
β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin 13
What are the pharmacotherapy options for treating prediabetes? 12
The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus 12
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications 9
Effect of fasting on short-term visual plasticity in adult humans 6
Totale 7.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020735 0 0 0 0 0 0 144 141 128 127 144 51
2020/2021708 56 59 54 29 40 38 36 97 67 83 55 94
2021/2022770 19 42 20 33 143 112 30 31 46 25 48 221
2022/20231.160 142 171 102 85 83 127 26 99 209 9 83 24
2023/2024907 75 92 89 70 124 128 64 25 23 54 61 102
2024/20251.084 66 122 86 167 278 309 56 0 0 0 0 0
Totale 7.741